“PET-Based Risk Assessment Tool for Predicting Outcomes in Large B-Cell Lymphoma Patients Undergoing CAR T-Cell Therapy”

https://pubmed.ncbi.nlm.nih.gov/38114616

This study developed a PET-based risk assessment tool to predict outcomes in large B-cell lymphoma patients undergoing CAR T-cell therapy, incorporating extra-nodal involvement and metabolic tumor volume (MTV) to improve accuracy.